TNFSF14 binds with TNFRSF14 to deliver costimulatory signals to T cells that are capable of causing significant changes in the TME and induce an anti-tumor immune response, indicating that they might be useful in enhancing cancer immunotherapy [41, 42]. The gene discussed is TNFRSF14; the disease is neoplasm.